BioCryst Pharmaceuticals | BCRX - Eigenkapital Und Reserven





Eigenkapital Und Reserven Veränderung Datum
Alnylam Pharmaceuticals USD 1.08B 286.2M 2026-03
BioCryst Pharmaceuticals USD -553.84M 434.69M 2026-03
Chugai Pharma JPY 2.03T 135.62B 2025-12
Daiichi Sankyo JPY 1.71T 57.86B 2025-12
DBV Technologies USD 207.9M 39.13M 2026-03
Enanta Pharmaceuticals USD 126.59M 61.87M 2025-12
Gilead Sciences USD 23.52B 897M 2026-03
GlaxoSmithKline GBP 17.42B 1.05B 2026-03
Glaxosmithkline GBP 17.42B 4.64B 2026-03
Incyte USD 5.62B 455.37M 2026-03
Ionis Pharmaceuticals USD 491.41M 2.32M 2026-03
Karyopharm Therapeutics USD -292.93M 23.67M 2025-12
Neurocrine Biosciences USD 3.41B 154.3M 2026-03
Novavax USD -144.76M 17.01M 2026-03
PTC Therapeutics USD -180.46M 24.85M 2026-03
Regeneron Pharmaceuticals USD 31.42B 166.7M 2026-03
Roche Holding CHF 33.8B 758M 2025-12
Sarepta Therapeutics USD 1.51B 364.48M 2026-03
Ultragenyx Pharmaceutical USD -236M 156M 2026-03
Vertex Pharmaceuticals USD 19.36B 696.1M 2026-03